ASSOCIATION BETWEEN ENLARGED GENITAL HIATUS AND PROLAPSE WITH OVERACTIVE BLADDER 1 YEAR AFTER VAGINAL DELIVERY

Pregnancy and Childbirth

Cesarean delivery is associated with lower neonatal mortality among breech pregnancies - a systematic review and meta-analysis of preterm deliveries ≤32 weeks of gestation

Am J Obstet Gynecol

Unger V, Gasparics Á, Nagy Z, Hernádfői M, Nagy R, Walter A, Farkas N, Szabó M, Hegyi P, Garami M, Varga P

doi: 10.1016/j.ajog.2024.06.015

Overactive BladderUrinary Incontinence

Gene Therapy With URO-902 (pVAX/hSlo) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial

J Urol

Enemchukwu EA, Kalota S, Robertson K, Ge S, Lu J, Badger H, Mujais S, Peters KM

doi: 10.1097/JU.0000000000004373

Pregnancy and Childbirth

Acute pain management after vaginal delivery with perineal tears or episiotomy

Reg Anesth Pain Med

Luxey X, Lemoine A, Dewinter G, Joshi G, Le Ray C, Raeder J, Van de Velde M, Bonnet MP, PROSPECT Working Group of the European Society of Regional Anesthesia and Pain Therapy

doi: 10.1136/rapm-2024-105478

Pregnancy and Childbirth

Incidence of neonatal respiratory morbidity after vaginal and caesarean delivery in the late-preterm and term period - a retrospective cohort study

Swiss Med Wkly

Gromann J, Mancino I, Manegold-Brauer G, Adams M, Wellmann S, Burkhardt T

doi: 10.57187/s.3798

Benign Prostatic Hyperplasia (BPH)

Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial

J Urol

Staskin D, Owens-Grillo J, Thomas E, Rovner E, Cline K, Mujais S

doi: 10.1097/JU.0000000000003999

Overactive Bladder

The mechanism of action of neuromodulation in the treatment of overactive bladder

Nat Rev Urol

Krhut J, Kobberø H, Kanaan R, Fode M, Poulsen M, Zvara P

doi: 10.1038/s41585-024-00967-8

Benign Prostatic Hyperplasia (BPH)

Surgery for benign prostate enlargement in England: 10-year retrospective study of 155 874 patients

BJU Int

Page T, O'Toole E, Keltie K, Abdelmotagly Y, Richardson H, Parker R, Sims AJ

doi: 10.1111/bju.16713

Erectile and Sexual Functions and DysfunctionsMenopause

A randomized trial on the safety and efficacy of sensate water-based and silicone-based personal lubricants for relief of intimate discomfort associated with vaginal dryness

J Sex Med

Krychman M, Hemmady K, Su L, Hood S, Gaifieva S, Palacios S

doi: 10.1093/jsxmed/qdaf058

Overactive Bladder

Antibiotic therapy for treating overactive bladder is not supported by clinical evidence

Nat Rev Urol

Pereca J, Wagg A, Kennedy M, Chapple C

doi: 10.1038/s41585-024-00974-9

Related content

Cesarean delivery is associated with lower neonatal mortality among breech pregnancies - a systematic review and meta-analysis of preterm deliveries ≤32 weeks of gestation

Gene Therapy With URO-902 (pVAX/hSlo) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial

Acute pain management after vaginal delivery with perineal tears or episiotomy

Incidence of neonatal respiratory morbidity after vaginal and caesarean delivery in the late-preterm and term period - a retrospective cohort study

Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial

The mechanism of action of neuromodulation in the treatment of overactive bladder

Surgery for benign prostate enlargement in England: 10-year retrospective study of 155 874 patients

A randomized trial on the safety and efficacy of sensate water-based and silicone-based personal lubricants for relief of intimate discomfort associated with vaginal dryness

Antibiotic therapy for treating overactive bladder is not supported by clinical evidence